Mistletoe Therapy
Mistletoe therapy (Viscum Album) is the most widely researched complementary cancer treatment in Europe, supported by more than 100 clinical studies. This guide addresses common questions about using mistletoe extract in cancer care.
When to Start
Mistletoe therapy can begin at any point after cancer diagnosis. Starting immediately after diagnosis and prior to surgery is often recommended, as it may strengthen the immune system before surgical stress. Treatment is typically long-term, lasting several years depending on disease progression and individual response.
Compatibility with Other Treatments
Mistletoe therapy can be used alongside chemotherapy and radiation. However, injections should avoid irradiated skin areas to prevent inflammation. No known drug interactions exist, though combined use with other biological therapies requires experienced practitioners.
How It Works
Viscum Album contains proteins that stimulate the immune system’s response to cancer cells. The extract must be injected because oral intake would destroy these active proteins during digestion.
Administration: Small doses are injected subcutaneously (under the skin of the abdomen or thigh), typically every other day or on a Monday/Wednesday/Friday schedule. Morning administration between 7:00 and 9:00 AM is recommended for optimal immune stimulation. The procedure uses fine needles and causes minimal discomfort.
Temperature monitoring: Patients track their body temperature to monitor treatment effects. A mild fever response (up to 100.4°F) is considered desirable, as it indicates the body’s immune system is responding to the therapy.
Expected Effects
Common responses (not allergic reactions):
- Skin reddening and mild itching at the injection site – these are immune response indicators
- Mild fever – considered beneficial for immune activation
Reported clinical benefits:
- Reduced side effects from chemotherapy and radiotherapy
- Improved infection resistance
- Enhanced sleep quality
- Decreased pain
- Restored appetite and life motivation
- Potential slowing of cancer progression, even in metastatic cases
Special Considerations
Lymphoma: Some oncologists express theoretical concerns about stimulating lymphoma growth with mistletoe. However, clinical experience shows that “positive experiences are seen to predominate” and negative effects have not been documented.
Solid tumors: Research indicates mistletoe proves most effective for solid tumors (breast cancer, melanoma, ovarian cancer) when used alongside conventional care.
Important
Mistletoe therapy requires prescription and supervision by an experienced anthroposophic physician. It is not appropriate for self-administration.
For more information about our cancer care program, see our Cancer Care page or contact us.